Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNHD1 DNAH2 DNAH5 DNAH8	5.35e-06	18	133	4	GO:0008569
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNHD1 DNAH2 DNAH5 DNAH8	3.40e-05	28	133	4	GO:0051959
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNHD1 DNAH2 DNAH5 DNAH8	1.05e-04	37	133	4	GO:0045505
GeneOntologyMolecularFunction	ATP hydrolysis activity	MYH4 ABCC4 DNAH2 RFC5 ATAD2 ABCB4 MLH3 HFM1 DNAH5 DNAH8 FIGNL1	1.81e-04	441	133	11	GO:0016887
GeneOntologyMolecularFunction	ATP-dependent activity	DNHD1 MYH4 ABCC4 DNAH2 RFC5 ATAD2 ABCB4 MLH3 HFM1 DNAH5 DNAH8 FIGNL1 TOP2A	2.36e-04	614	133	13	GO:0140657
GeneOntologyMolecularFunction	structural constituent of cytoskeleton	TUBB8 TLN2 PLEC DMD TUBD1 TUBB8B	2.37e-04	130	133	6	GO:0005200
GeneOntologyMolecularFunction	pyrophosphatase activity	PRUNE2 MYH4 NUGGC ABCC4 TUBB8 DNAH2 RFC5 ATAD2 ABCB4 MLH3 HFM1 DNAH5 DNAH8 FIGNL1 TUBB8B	4.76e-04	839	133	15	GO:0016462
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides	PRUNE2 MYH4 NUGGC ABCC4 TUBB8 DNAH2 RFC5 ATAD2 ABCB4 MLH3 HFM1 DNAH5 DNAH8 FIGNL1 TUBB8B	4.82e-04	840	133	15	GO:0016817
GeneOntologyMolecularFunction	hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides	PRUNE2 MYH4 NUGGC ABCC4 TUBB8 DNAH2 RFC5 ATAD2 ABCB4 MLH3 HFM1 DNAH5 DNAH8 FIGNL1 TUBB8B	4.82e-04	840	133	15	GO:0016818
GeneOntologyMolecularFunction	ribonucleoside triphosphate phosphatase activity	MYH4 NUGGC ABCC4 TUBB8 DNAH2 RFC5 ATAD2 ABCB4 MLH3 HFM1 DNAH5 DNAH8 FIGNL1 TUBB8B	6.70e-04	775	133	14	GO:0017111
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization	TPR TUBB8 DNAH2 APC HAUS3 SIK3 CCNF HDAC3 BRCA2 SYNE2 PKD1 TUBD1 DNAH5 DNAH8 FIGNL1 TUBB8B	1.36e-05	720	131	16	GO:0000226
GeneOntologyCellularComponent	axonemal dynein complex	DNHD1 DNAH2 DNAH5 DNAH8	1.89e-05	25	135	4	GO:0005858
GeneOntologyCellularComponent	dynein complex	DNHD1 TPR DNAH2 DNAH5 DNAH8	2.56e-05	54	135	5	GO:0030286
GeneOntologyCellularComponent	microtubule associated complex	DNHD1 TPR DCTN5 DNAH2 HAUS3 DNAH5 DNAH8	8.56e-05	161	135	7	GO:0005875
GeneOntologyCellularComponent	condensed chromosome	TPR DCTN5 APC MLH3 BRCA2 BUB1 SMARCD1 SMARCD2 TOP2A	1.75e-04	307	135	9	GO:0000793
GeneOntologyCellularComponent	supramolecular fiber	LRRC39 MICAL1 MYH4 ENKUR EPPK1 TUBB8 LRRC49 CEP57L1 DNAH2 APC HAUS3 RYR3 SYNE2 PLEC DMD TUBD1 DNAH5 DNAH8 TUBB8B	2.08e-04	1179	135	19	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	LRRC39 MICAL1 MYH4 ENKUR EPPK1 TUBB8 LRRC49 CEP57L1 DNAH2 APC HAUS3 RYR3 SYNE2 PLEC DMD TUBD1 DNAH5 DNAH8 TUBB8B	2.27e-04	1187	135	19	GO:0099081
GeneOntologyCellularComponent	UBC13-MMS2 complex	UBE2V1 UBE2V2	2.46e-04	4	135	2	GO:0031372
GeneOntologyCellularComponent	dystrophin-associated glycoprotein complex	SGCB DMD UTRN	2.77e-04	20	135	3	GO:0016010
GeneOntologyCellularComponent	filopodium membrane	SYNE2 DMD UTRN	3.22e-04	21	135	3	GO:0031527
GeneOntologyCellularComponent	chromosome, centromeric region	TPR DCTN5 APC ESCO2 BUB1 SMARCD1 SMARCD2 TOP2A	4.36e-04	276	135	8	GO:0000775
GeneOntologyCellularComponent	glycoprotein complex	SGCB DMD UTRN	5.46e-04	25	135	3	GO:0090665
GeneOntologyCellularComponent	9+0 motile cilium	ENKUR DNAH5	6.11e-04	6	135	2	GO:0097728
GeneOntologyCellularComponent	platelet dense granule membrane	ABCC4 LAMP2	6.11e-04	6	135	2	GO:0031088
GeneOntologyCellularComponent	ficolin-1-rich granule membrane	LAMP2 SERPINB6 SERPINB10 SLC11A1	6.53e-04	61	135	4	GO:0101003
GeneOntologyCellularComponent	microtubule	ENKUR TUBB8 LRRC49 CEP57L1 DNAH2 APC HAUS3 TUBD1 DNAH5 DNAH8 TUBB8B	6.95e-04	533	135	11	GO:0005874
GeneOntologyCellularComponent	polymeric cytoskeletal fiber	MICAL1 ENKUR EPPK1 TUBB8 LRRC49 CEP57L1 DNAH2 APC HAUS3 PLEC DMD TUBD1 DNAH5 DNAH8 TUBB8B	7.11e-04	899	135	15	GO:0099513
GeneOntologyCellularComponent	kinetochore	TPR DCTN5 APC BUB1 SMARCD1 SMARCD2	1.16e-03	181	135	6	GO:0000776
GeneOntologyCellularComponent	ubiquitin conjugating enzyme complex	UBE2V1 UBE2V2	1.45e-03	9	135	2	GO:0031371
GeneOntologyCellularComponent	condensed chromosome, centromeric region	TPR DCTN5 APC BUB1 SMARCD1 SMARCD2	1.61e-03	193	135	6	GO:0000779
GeneOntologyCellularComponent	chromosomal region	TPR DCTN5 APC ESCO2 BRCA2 BUB1 SMARCD1 SMARCD2 TOP2A	1.68e-03	421	135	9	GO:0098687
GeneOntologyCellularComponent	inner dynein arm	DNHD1 DNAH2	1.80e-03	10	135	2	GO:0036156
GeneOntologyCellularComponent	hemidesmosome	EPPK1 PLEC	2.19e-03	11	135	2	GO:0030056
GeneOntologyCellularComponent	outer dynein arm	DNAH5 DNAH8	2.62e-03	12	135	2	GO:0036157
Domain	Spectrin_repeat	SYNE2 PLEC DMD MCF2L UTRN	1.76e-06	29	133	5	IPR002017
Domain	Dynein_HC_stalk	DNHD1 DNAH2 DNAH5 DNAH8	2.33e-06	14	133	4	IPR024743
Domain	Dynein_heavy_dom-2	DNHD1 DNAH2 DNAH5 DNAH8	2.33e-06	14	133	4	IPR013602
Domain	DHC_N2	DNHD1 DNAH2 DNAH5 DNAH8	2.33e-06	14	133	4	PF08393
Domain	MT	DNHD1 DNAH2 DNAH5 DNAH8	2.33e-06	14	133	4	PF12777
Domain	SPEC	SYNE2 PLEC DMD MCF2L UTRN	2.93e-06	32	133	5	SM00150
Domain	Spectrin/alpha-actinin	SYNE2 PLEC DMD MCF2L UTRN	2.93e-06	32	133	5	IPR018159
Domain	DHC_fam	DNHD1 DNAH2 DNAH5 DNAH8	3.16e-06	15	133	4	IPR026983
Domain	Dynein_heavy	DNHD1 DNAH2 DNAH5 DNAH8	3.16e-06	15	133	4	PF03028
Domain	Dynein_heavy_dom	DNHD1 DNAH2 DNAH5 DNAH8	3.16e-06	15	133	4	IPR004273
Domain	AAA	ABCC4 DNAH2 RFC5 ATAD2 ABCB4 DNAH5 DNAH8 FIGNL1	8.94e-06	144	133	8	SM00382
Domain	AAA+_ATPase	ABCC4 DNAH2 RFC5 ATAD2 ABCB4 DNAH5 DNAH8 FIGNL1	8.94e-06	144	133	8	IPR003593
Domain	DHC_N1	DNAH2 DNAH5 DNAH8	1.93e-05	8	133	3	PF08385
Domain	Dynein_heavy_dom-1	DNAH2 DNAH5 DNAH8	1.93e-05	8	133	3	IPR013594
Domain	Spectrin	SYNE2 DMD MCF2L UTRN	1.96e-05	23	133	4	PF00435
Domain	ACTININ_2	SYNE2 PLEC DMD UTRN	1.96e-05	23	133	4	PS00020
Domain	ACTININ_1	SYNE2 PLEC DMD UTRN	1.96e-05	23	133	4	PS00019
Domain	Actinin_actin-bd_CS	SYNE2 PLEC DMD UTRN	1.96e-05	23	133	4	IPR001589
Domain	Dystrophin	DMD UTRN	5.03e-05	2	133	2	IPR016344
Domain	CRAL_TRIO_2	PRUNE2 GDAP2 MCF2L	7.41e-05	12	133	3	PF13716
Domain	CH	MICAL1 SYNE2 PLEC DMD UTRN	9.96e-05	65	133	5	SM00033
Domain	Dynein_heavy_chain_D4_dom	DNAH2 DNAH5 DNAH8	1.21e-04	14	133	3	IPR024317
Domain	ATPase_dyneun-rel_AAA	DNAH2 DNAH5 DNAH8	1.21e-04	14	133	3	IPR011704
Domain	AAA_8	DNAH2 DNAH5 DNAH8	1.21e-04	14	133	3	PF12780
Domain	AAA_5	DNAH2 DNAH5 DNAH8	1.21e-04	14	133	3	PF07728
Domain	CH	MICAL1 SYNE2 PLEC DMD UTRN	1.42e-04	70	133	5	PF00307
Domain	Ago_hook	TNRC6B TNRC6A	1.50e-04	3	133	2	PF10427
Domain	SWIB_domain	SMARCD1 SMARCD2	1.50e-04	3	133	2	IPR019835
Domain	SWIB	SMARCD1 SMARCD2	1.50e-04	3	133	2	SM00151
Domain	TNRC6_PABC-bd	TNRC6B TNRC6A	1.50e-04	3	133	2	IPR032226
Domain	Argonaute_hook_dom	TNRC6B TNRC6A	1.50e-04	3	133	2	IPR019486
Domain	TNRC6-PABC_bdg	TNRC6B TNRC6A	1.50e-04	3	133	2	PF16608
Domain	-	MICAL1 SYNE2 PLEC DMD UTRN	1.52e-04	71	133	5	1.10.418.10
Domain	CH	MICAL1 SYNE2 PLEC DMD UTRN	1.73e-04	73	133	5	PS50021
Domain	CH-domain	MICAL1 SYNE2 PLEC DMD UTRN	1.97e-04	75	133	5	IPR001715
Domain	KN_motif	KANK2 KANK1	2.99e-04	4	133	2	IPR021939
Domain	KN_motif	KANK2 KANK1	2.99e-04	4	133	2	PF12075
Domain	SWIB	SMARCD1 SMARCD2	4.96e-04	5	133	2	PF02201
Domain	SEC14	PRUNE2 GDAP2 MCF2L	7.24e-04	25	133	3	SM00516
Domain	Leu-rich_rpt	NLRP11 LRRC39 LRRC34 LRRC49 TLR8 CEP78 TLR1 PKD1	7.28e-04	271	133	8	IPR001611
Domain	-	EPPK1 PLEC	7.41e-04	6	133	2	3.90.1290.10
Domain	-	SMARCD1 SMARCD2	7.41e-04	6	133	2	1.10.245.10
Domain	EF-hand_dom_typ1	DMD UTRN	7.41e-04	6	133	2	IPR015153
Domain	EF-hand_dom_typ2	DMD UTRN	7.41e-04	6	133	2	IPR015154
Domain	EF-hand_2	DMD UTRN	7.41e-04	6	133	2	PF09068
Domain	EF-hand_3	DMD UTRN	7.41e-04	6	133	2	PF09069
Domain	SWIB_MDM2_domain	SMARCD1 SMARCD2	7.41e-04	6	133	2	IPR003121
Domain	CRAL_TRIO	PRUNE2 GDAP2 MCF2L	9.11e-04	27	133	3	PS50191
Domain	CRAL-TRIO_dom	PRUNE2 GDAP2 MCF2L	1.02e-03	28	133	3	IPR001251
Domain	Plectin	EPPK1 PLEC	1.03e-03	7	133	2	PF00681
Domain	Plectin_repeat	EPPK1 PLEC	1.03e-03	7	133	2	IPR001101
Domain	PLEC	EPPK1 PLEC	1.03e-03	7	133	2	SM00250
Domain	-	NLRP11 LRRC39 LRRC34 LRRC49 TLR8 CEP78 TLR1 PKD1	2.13e-03	321	133	8	3.80.10.10
Domain	L_dom-like	NLRP11 LRRC39 LRRC34 LRRC49 TLR8 CEP78 TLR1 PKD1	2.44e-03	328	133	8	IPR032675
Domain	PKD	TMEM130 PKD1	2.65e-03	11	133	2	PS50093
Domain	PKD_dom	TMEM130 PKD1	2.65e-03	11	133	2	IPR000601
Domain	-	TMEM130 PKD1	2.65e-03	11	133	2	2.60.40.670
Domain	UQ_con	UBE2V1 UBE2V2 UBE2Z	2.68e-03	39	133	3	PF00179
Domain	ARM	APC ARMCX2 AP1B1	2.88e-03	40	133	3	SM00185
Domain	UBIQUITIN_CONJUGAT_1	UBE2V1 UBE2V2 UBE2Z	2.88e-03	40	133	3	PS00183
Domain	UBIQUITIN_CONJUGAT_2	UBE2V1 UBE2V2 UBE2Z	3.09e-03	41	133	3	PS50127
Domain	UBQ-conjugat_E2	UBE2V1 UBE2V2 UBE2Z	3.09e-03	41	133	3	IPR000608
Domain	Armadillo	APC ARMCX2 AP1B1	4.55e-03	47	133	3	IPR000225
Domain	AAA	RFC5 ATAD2 FIGNL1	6.05e-03	52	133	3	PF00004
Domain	MAM	ZAN MALRD1	6.38e-03	17	133	2	SM00137
Domain	ATPase_AAA_core	RFC5 ATAD2 FIGNL1	6.72e-03	54	133	3	IPR003959
Domain	-	DNHD1 NUGGC ABCC4 DNAH2 RFC5 ATAD2 ABCB4 CASK HFM1 DNAH5 DNAH8 FIGNL1	7.04e-03	746	133	12	3.40.50.300
Domain	LRR_6	NLRP11 LRRC34 CEP78	7.07e-03	55	133	3	PF13516
Pathway	KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT	DCTN5 TUBB8 DNAH2 DNAH5 DNAH8	8.40e-06	43	92	5	M47669
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT	DCTN5 TUBB8 DNAH2 DNAH5 DNAH8	1.05e-05	45	92	5	M47670
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT	DCTN5 DNAH2 DNAH5 DNAH8	2.66e-05	27	92	4	M47755
Pathway	REACTOME_CELL_CYCLE	TPR TUBB8 HAUS3 RFC5 ESCO2 MLH3 CEP78 BRCA2 UBE2V2 SYNE2 BUB1 FIGNL1 TUBB8B TOP2A	1.53e-04	694	92	14	M543
Pathway	REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS	TUBB8 GRIN2A CASK TUBB8B	1.89e-04	44	92	4	M27934
Pathway	WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY	TLR8 UBE2V1 TLR1	2.04e-04	18	92	3	M39478
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	TUBB8 TBC1D5 APC TNRC6B HAUS3 SIK3 ECPAS RFC5 KANK2 HDAC3 BRCA2 TNRC6A TMEM131 TANC1 PLEC TOP2A ZC3HAV1	4.35e-08	853	136	17	28718761
Pubmed	Systemic investigation of bone and muscle abnormalities in dystrophin/utrophin double knockout mice during postnatal development and the mechanisms.	TNFSF11 DMD UTRN	2.33e-07	4	136	3	30689868
Pubmed	Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan.	PLEC DMD UTRN	2.33e-07	4	136	3	17389230
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TPR TBC1D5 DLGAP4 APC TNRC6B GRIN2A SIK3 GRM1 KANK2 CASK HDAC3 AP1B1 UBE2V1 UBE2V2 SYNE2 MIOS TLN2	2.43e-07	963	136	17	28671696
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	FYTTD1 POLR1A DCTN5 TUBB8 APC TNRC6B LAMP2 RFC5 ATAD2 FOXJ3 KANK2 STAT1 CASK HDAC3 LNPEP TNRC6A MIOS TANC1 UTRN TBL2 ZC3HAV1	3.84e-07	1497	136	21	31527615
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	NLRP11 DNHD1 TPR SLC15A1 PLEC DMD DNAH5 TOP2A ZC3HAV1	3.86e-07	234	136	9	36243803
Pubmed	Ex vivo stretch reveals altered mechanical properties of isolated dystrophin-deficient hearts.	SGCB DMD UTRN	5.82e-07	5	136	3	22427904
Pubmed	Kinetics of cardiac muscle contraction and relaxation are linked and determined by properties of the cardiac sarcomere.	LAMP2 DMD UTRN	5.82e-07	5	136	3	20656885
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TPR LRRC49 APC TNRC6B ECPAS RBM20 BRCA2 BUB1 TNRC6A PLEC UTRN	8.42e-07	418	136	11	34709266
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	FAT4 DNAH2 ALG11 SIK3 CSMD2 FOXJ3 RAD51AP2 AP1B1 SYNE2 SMARCD1 HFM1 MCF2L TBL2	1.45e-06	638	136	13	31182584
Pubmed	Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle.	SGCB DMD UTRN	2.02e-06	7	136	3	1461282
Pubmed	Isolation of several human axonemal dynein heavy chain genes: genomic structure of the catalytic site, phylogenetic analysis and chromosomal assignment.	DNAH2 DNAH5 DNAH8	2.02e-06	7	136	3	9256245
Pubmed	Cytoplasmic gamma-actin expression in diverse animal models of muscular dystrophy.	SGCB DMD UTRN	2.02e-06	7	136	3	17475492
Pubmed	Mutations in DNAH17, Encoding a Sperm-Specific Axonemal Outer Dynein Arm Heavy Chain, Cause Isolated Male Infertility Due to Asthenozoospermia.	DNAH2 DNAH5 DNAH8	2.02e-06	7	136	3	31178125
Pubmed	Proximity labeling reveals dynamic changes in the SQSTM1 protein network.	TNRC6B LZIC KANK1 MAP4K5 NYNRIN BUB1 TNRC6A MIOS TANC1	5.35e-06	322	136	9	39098523
Pubmed	Systematic interactome mapping of acute lymphoblastic leukemia cancer gene products reveals EXT-1 tumor suppressor as a Notch1 and FBWX7 common interactor.	CEP57L1 STAT1 MLH3 UBE2V2 TNRC6A FIGNL1 DKK3	6.36e-06	176	136	7	27229929
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	DNHD1 TUBB8 SYNE2 PKD1 PLEC DMD DNAH8	9.45e-06	187	136	7	26460568
Pubmed	miR-30 family microRNAs regulate myogenic differentiation and provide negative feedback on the microRNA pathway.	TNRC6A SMARCD2 DMD	1.25e-05	12	136	3	25689854
Pubmed	Secreted TARSH regulates olfactory mitral cell dendritic complexity.	PRUNE2 ABI3BP TBX21	1.25e-05	12	136	3	19302145
Pubmed	Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.	DMD UTRN	1.52e-05	2	136	2	10525423
Pubmed	In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.	DMD UTRN	1.52e-05	2	136	2	28790199
Pubmed	Metabolic dysfunction and altered mitochondrial dynamics in the utrophin-dystrophin deficient mouse model of duchenne muscular dystrophy.	DMD UTRN	1.52e-05	2	136	2	25859846
Pubmed	G-utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain.	DMD UTRN	1.52e-05	2	136	2	7731967
Pubmed	Role of GW182 protein in the cell.	TNRC6B TNRC6A	1.52e-05	2	136	2	29791863
Pubmed	Role of dystrophin and utrophin for assembly and function of the dystrophin glycoprotein complex in non-muscle tissue.	DMD UTRN	1.52e-05	2	136	2	16710609
Pubmed	Nonclinical Exon Skipping Studies with 2'-O-Methyl Phosphorothioate Antisense Oligonucleotides in mdx and mdx-utrn-/- Mice Inspired by Clinical Trial Results.	DMD UTRN	1.52e-05	2	136	2	30672725
Pubmed	Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis.	DMD UTRN	1.52e-05	2	136	2	7962191
Pubmed	Talin2 and KANK2 functionally interact to regulate microtubule dynamics, paclitaxel sensitivity and cell migration in the MDA-MB-435S melanoma cell line.	KANK2 TLN2	1.52e-05	2	136	2	37460977
Pubmed	Contraction-Induced Loss of Plasmalemmal Electrophysiological Function Is Dependent on the Dystrophin Glycoprotein Complex.	SGCB DMD	1.52e-05	2	136	2	34764884
Pubmed	Does utrophin expression in muscles of mdx mice during postnatal development functionally compensate for dystrophin deficiency?	DMD UTRN	1.52e-05	2	136	2	8021701
Pubmed	Plakins in development and disease.	EPPK1 PLEC	1.52e-05	2	136	2	17499243
Pubmed	Correlation of Utrophin Levels with the Dystrophin Protein Complex and Muscle Fibre Regeneration in Duchenne and Becker Muscular Dystrophy Muscle Biopsies.	DMD UTRN	1.52e-05	2	136	2	26974331
Pubmed	Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy.	DMD UTRN	1.52e-05	2	136	2	28453658
Pubmed	A quantitative study of bioenergetics in skeletal muscle lacking utrophin and dystrophin.	DMD UTRN	1.52e-05	2	136	2	11801396
Pubmed	Apo-dystrophin-1 and apo-dystrophin-2, products of the Duchenne muscular dystrophy locus: expression during mouse embryogenesis and in cultured cell lines.	DMD UTRN	1.52e-05	2	136	2	7987307
Pubmed	Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model.	APC SLC15A1	1.52e-05	2	136	2	27458604
Pubmed	Comparative analysis of the human dystrophin and utrophin gene structures.	DMD UTRN	1.52e-05	2	136	2	11861579
Pubmed	Distinct mechanical properties in homologous spectrin-like repeats of utrophin.	DMD UTRN	1.52e-05	2	136	2	30914715
Pubmed	Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.	DMD UTRN	1.52e-05	2	136	2	22284942
Pubmed	Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice.	DMD UTRN	1.52e-05	2	136	2	17889902
Pubmed	Matricellular Protein CCN5 Gene Transfer Ameliorates Cardiac and Skeletal Dysfunction in mdx/utrn (±) Haploinsufficient Mice by Reducing Fibrosis and Upregulating Utrophin Expression.	DMD UTRN	1.52e-05	2	136	2	35557546
Pubmed	Characterization of the Ang/Tie2 Signaling Pathway in the Diaphragm Muscle of DMD Mice.	DMD UTRN	1.52e-05	2	136	2	37626761
Pubmed	Molecular heterogeneity of the dystrophin-associated protein complex in the mouse kidney nephron: differential alterations in the absence of utrophin and dystrophin.	DMD UTRN	1.52e-05	2	136	2	15565469
Pubmed	Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse.	SGCB DMD	1.52e-05	2	136	2	24723230
Pubmed	The N- and C-Terminal Domains Differentially Contribute to the Structure and Function of Dystrophin and Utrophin Tandem Calponin-Homology Domains.	DMD UTRN	1.52e-05	2	136	2	26516677
Pubmed	Assessment of cardiac function in three mouse dystrophinopathies by magnetic resonance imaging.	DMD UTRN	1.52e-05	2	136	2	22209498
Pubmed	Overexpression of Dickkopf 3 in hepatoblastomas and hepatocellular carcinomas.	AFP DKK3	1.52e-05	2	136	2	19437037
Pubmed	A mechano-signalling network linking microtubules, myosin IIA filaments and integrin-based adhesions.	KANK2 KANK1	1.52e-05	2	136	2	31114072
Pubmed	A Protocol for Simultaneous In Vivo Imaging of Cardiac and Neuroinflammation in Dystrophin-Deficient MDX Mice Using [18F]FEPPA PET.	DMD UTRN	1.52e-05	2	136	2	37108685
Pubmed	Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.	DMD UTRN	1.52e-05	2	136	2	10694796
Pubmed	Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis.	TBX21 STAT1	1.52e-05	2	136	2	15238607
Pubmed	Enhanced currents through L-type calcium channels in cardiomyocytes disturb the electrophysiology of the dystrophic heart.	DMD UTRN	1.52e-05	2	136	2	24337461
Pubmed	Activation of calcineurin and stress activated protein kinase/p38-mitogen activated protein kinase in hearts of utrophin-dystrophin knockout mice.	DMD UTRN	1.52e-05	2	136	2	11297940
Pubmed	Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping.	DMD UTRN	1.52e-05	2	136	2	22388933
Pubmed	Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers.	DMD UTRN	1.52e-05	2	136	2	25642938
Pubmed	Satellite cells and utrophin are not directly correlated with the degree of skeletal muscle damage in mdx mice.	DMD UTRN	1.52e-05	2	136	2	15703201
Pubmed	Utrophin suppresses low frequency oscillations and coupled gating of mechanosensitive ion channels in dystrophic skeletal muscle.	DMD UTRN	1.52e-05	2	136	2	25941878
Pubmed	Duchenne muscular dystrophy and the neuromuscular junction: the utrophin link.	DMD UTRN	1.52e-05	2	136	2	9297964
Pubmed	SERCA1 overexpression minimizes skeletal muscle damage in dystrophic mouse models.	DMD UTRN	1.52e-05	2	136	2	25652448
Pubmed	Utrophin Compensates dystrophin Loss during Mouse Spermatogenesis.	DMD UTRN	1.52e-05	2	136	2	28785010
Pubmed	Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy.	DMD UTRN	1.52e-05	2	136	2	16307000
Pubmed	Expression of the dystrophin isoform Dp116 preserves functional muscle mass and extends lifespan without preventing dystrophy in severely dystrophic mice.	DMD UTRN	1.52e-05	2	136	2	21949353
Pubmed	Dystrophin and utrophin "double knockout" dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities.	DMD UTRN	1.52e-05	2	136	2	23097179
Pubmed	The role of utrophin and Dp71 for assembly of different dystrophin-associated protein complexes (DPCs) in the choroid plexus and microvasculature of the brain.	DMD UTRN	1.52e-05	2	136	2	15501597
Pubmed	Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.	DMD UTRN	1.52e-05	2	136	2	11257121
Pubmed	Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice.	DMD UTRN	1.52e-05	2	136	2	18973234
Pubmed	Renin-angiotensin-aldosterone system inhibitors improve membrane stability and change gene-expression profiles in dystrophic skeletal muscles.	DMD UTRN	1.52e-05	2	136	2	27881412
Pubmed	Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies.	DMD UTRN	1.52e-05	2	136	2	20625423
Pubmed	Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle.	DMD UTRN	1.52e-05	2	136	2	29065908
Pubmed	Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy.	DMD UTRN	1.52e-05	2	136	2	31039133
Pubmed	Developmentally regulated expression and localization of dystrophin and utrophin in the human fetal brain.	DMD UTRN	1.52e-05	2	136	2	11796130
Pubmed	Dystrophin and dystrophin-related protein in the brains of normal and mdx mice.	DMD UTRN	1.52e-05	2	136	2	8159184
Pubmed	Dystrophin and utrophin: genetic analyses of their role in skeletal muscle.	DMD UTRN	1.52e-05	2	136	2	10679963
Pubmed	TAT-μUtrophin mitigates the pathophysiology of dystrophin and utrophin double-knockout mice.	DMD UTRN	1.52e-05	2	136	2	21565990
Pubmed	Generation and characterization of transgenic mice with the full-length human DMD gene.	DMD UTRN	1.52e-05	2	136	2	18083704
Pubmed	Dystrophin and dystrophin-related protein (utrophin) distribution in normal and dystrophin-deficient skeletal muscles.	DMD UTRN	1.52e-05	2	136	2	8186702
Pubmed	Contemporary cardiac issues in Duchenne muscular dystrophy. Working Group of the National Heart, Lung, and Blood Institute in collaboration with Parent Project Muscular Dystrophy.	DMD UTRN	1.52e-05	2	136	2	25940966
Pubmed	Cardiac dysfunction and pathology in the dystrophin and utrophin-deficient mouse during development of dilated cardiomyopathy.	DMD UTRN	1.52e-05	2	136	2	22266080
Pubmed	Postnatal overexpression of the CT GalNAc transferase inhibits muscular dystrophy in mdx mice without altering muscle growth or neuromuscular development: evidence for a utrophin-independent mechanism.	DMD UTRN	1.52e-05	2	136	2	17300937
Pubmed	Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice.	DMD UTRN	1.52e-05	2	136	2	21768542
Pubmed	Social stress is lethal in the mdx model of Duchenne muscular dystrophy.	DMD UTRN	1.52e-05	2	136	2	32192914
Pubmed	Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility.	BRCA2 AFP	1.52e-05	2	136	2	27690720
Pubmed	Metabolic remodeling of dystrophic skeletal muscle reveals biological roles for dystrophin and utrophin in adaptation and plasticity.	DMD UTRN	1.52e-05	2	136	2	33359740
Pubmed	Utrophin regulates modal gating of mechanosensitive ion channels in dystrophic skeletal muscle.	DMD UTRN	1.52e-05	2	136	2	24879867
Pubmed	Increased vulnerability to kainate-induced seizures in utrophin-knockout mice.	DMD UTRN	1.52e-05	2	136	2	12028357
Pubmed	Excitation-contraction coupling alterations in mdx and utrophin/dystrophin double knockout mice: a comparative study.	DMD UTRN	1.52e-05	2	136	2	20130206
Pubmed	Analysis of gene expression differences between utrophin/dystrophin-deficient vs mdx skeletal muscles reveals a specific upregulation of slow muscle genes in limb muscles.	DMD UTRN	1.52e-05	2	136	2	16525850
Pubmed	Persistent upregulation of the β-tubulin tubb6, linked to muscle regeneration, is a source of microtubule disorganization in dystrophic muscle.	SGCB DMD	1.52e-05	2	136	2	30535187
Pubmed	Distribution of dystrophin- and utrophin-associated protein complexes during activation of human neutrophils.	DMD UTRN	1.52e-05	2	136	2	20434517
Pubmed	Plasma lipidomic analysis shows a disease progression signature in mdx mice.	DMD UTRN	1.52e-05	2	136	2	34155298
Pubmed	Dystrophic changes in extraocular muscles after gamma irradiation in mdx:utrophin(+/-) mice.	DMD UTRN	1.52e-05	2	136	2	24466085
Pubmed	ESCO2 promotes hypopharyngeal carcinoma progression in a STAT1-dependent manner.	STAT1 ESCO2	1.52e-05	2	136	2	37968576
Pubmed	The Angiotensin Converting Enzyme Inhibitor Lisinopril Improves Muscle Histopathology but not Contractile Function in a Mouse Model of Duchenne Muscular Dystrophy.	DMD UTRN	1.52e-05	2	136	2	27110493
Pubmed	Rapid depletion of muscle progenitor cells in dystrophic mdx/utrophin-/- mice.	DMD UTRN	1.52e-05	2	136	2	24781208
Pubmed	Isolation and characterization of a genomic clone from the murine utrophin locus.	DMD UTRN	1.52e-05	2	136	2	8268660
Pubmed	Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.	DMD UTRN	1.52e-05	2	136	2	27037492
Pubmed	Improvement in survival and muscle function in an mdx/utrn(-/-) double mutant mouse using a human retinal dystrophin transgene.	DMD UTRN	1.52e-05	2	136	2	16487708
Pubmed	Voltage-gated ion channel dysfunction precedes cardiomyopathy development in the dystrophic heart.	DMD UTRN	1.52e-05	2	136	2	21677768
Pubmed	Integrative effects of dystrophin loss on metabolic function of the mdx mouse.	SGCB DMD	1.52e-05	2	136	2	30206270
Pubmed	Consequences of the combined deficiency in dystrophin and utrophin on the mechanical properties and myosin composition of some limb and respiratory muscles of the mouse.	DMD UTRN	1.52e-05	2	136	2	9713852
Interaction	PHF21A interactions	TPR LRRC49 APC TNRC6B ECPAS RBM20 ESCO2 BRCA2 BUB1 TNRC6A EXOC1 PLEC UTRN	4.98e-07	343	134	13	int:PHF21A
Interaction	HDAC1 interactions	TPR MYH4 LRRC49 APC TNRC6B ECPAS SKIL TFAP4 RBM20 STAT1 ESCO2 CCNF HDAC3 BRCA2 SYNE2 BUB1 TNRC6A SMARCD1 SMARCD2 PLEC UTRN TOP2A	3.85e-06	1108	134	22	int:HDAC1
Interaction	LYN interactions	PRUNE2 SLC25A41 POLR1A APC LAMP2 KANK2 CASK CCNF HDAC3 LNPEP MAP4K5 TGDS TANC1 DMD TUBD1 UTRN ZC3HAV1	5.95e-06	720	134	17	int:LYN
Cytoband	6q24	GRM1 UTRN	2.45e-04	8	137	2	6q24
Cytoband	9q21.2	PRUNE2 CEP78	3.92e-04	10	137	2	9q21.2
GeneFamily	Dyneins, axonemal	DNAH2 DNAH5 DNAH8	7.97e-05	17	91	3	536
GeneFamily	Ankyrin repeat domain containing\|KN motif and ankyrin repeat domain containing	KANK2 KANK1	1.49e-04	4	91	2	623
GeneFamily	Ataxins\|Trinucleotide repeat containing	TNRC6B CASK TNRC6A	2.62e-04	25	91	3	775
GeneFamily	Rho GTPase activating proteins\|BCH domain containing	PRUNE2 GDAP2	5.18e-04	7	91	2	1299
GeneFamily	EF-hand domain containing\|Plakins	EPPK1 PLEC	6.88e-04	8	91	2	939
GeneFamily	Cyclins\|F-boxes other	CCNF FBXO25 FBXO24	9.89e-04	39	91	3	560
GeneFamily	CD molecules\|Toll like receptors	TLR8 TLR1	1.10e-03	10	91	2	948
GeneFamily	Ubiquitin conjugating enzymes E2	UBE2V1 UBE2V2 UBE2Z	1.14e-03	41	91	3	102
GeneFamily	AAA ATPases	RFC5 ATAD2 FIGNL1	2.41e-03	53	91	3	413
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	DMD UTRN	3.64e-03	18	91	2	91
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	TPR FYTTD1 APC HAUS3 ATAD2 LZIC BRCA2 LNPEP MAP4K5 MIOS PLEC FIGNL1 TOP2A DKK3	2.04e-05	721	134	14	M10237
Coexpression	MARKEY_RB1_ACUTE_LOF_UP	HAUS3 RFC5 CCNF BRCA2 TGDS BUB1 TNRC6A FIGNL1	3.11e-05	237	134	8	M15606
Coexpression	MARKEY_RB1_ACUTE_LOF_UP	HAUS3 RFC5 CCNF BRCA2 TGDS BUB1 TNRC6A FIGNL1	3.40e-05	240	134	8	MM976
Coexpression	HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL	CEP57L1 ATAD2 ESCO2 CCNF CEP78 BRCA2 SYNE2 BUB1 SMARCD2 FIGNL1 TOP2A	3.63e-05	478	134	11	M45785
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	RFC5 ATAD2 TFAP4 ESCO2 CEP78 BRCA2 BUB1 FIGNL1 TOP2A	4.44e-05	323	134	9	M2156
Coexpression	WHITFIELD_CELL_CYCLE_LITERATURE	CCNF BRCA2 BUB1 TOP2A	7.57e-05	44	134	4	M2066
Coexpression	GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN	TBC1D5 APC ABCB4 BRCA2 LNPEP PLEC ZC3HAV1	7.61e-05	199	134	7	M6264
Coexpression	GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_DN	PRUNE2 ABCC4 ARMCX2 KANK1 TLR1 SMARCD1 UTRN	7.86e-05	200	134	7	M8027
Coexpression	GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP	LAMP2 GRIN2A RFC5 RYK HDAC3 UBE2V1 FIGNL1	7.86e-05	200	134	7	M9764
Coexpression	GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP	MICAL1 ABCC4 LRRC49 ATAD2 SERPINB6 SMARCD2 TBL2	7.86e-05	200	134	7	M7433
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 ZAN GRM1 PKHD1L1 RYR3 TLN2 DMD DNAH5 ANO3	6.01e-09	184	137	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 ZAN GRM1 PKHD1L1 RYR3 TLN2 DMD DNAH5 ANO3	6.01e-09	184	137	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 ZAN GRM1 PKHD1L1 RYR3 TLN2 DMD DNAH5 ANO3	6.01e-09	184	137	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TEDC2 TBX21 RFC5 ATAD2 ESCO2 CCNF CEP78 BUB1 TOP2A	7.25e-09	188	137	9	319fbeca200ab998daf49fcaee0bfdb57bf7ee4b
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	TEDC2 RFC5 ATAD2 ESCO2 CCNF BRCA2 SYNE2 BUB1 TOP2A	1.19e-08	199	137	9	305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TEDC2 RFC5 ATAD2 ESCO2 CCNF BRCA2 SYNE2 BUB1 TOP2A	1.19e-08	199	137	9	fba48342066aab41a8bcb20db40a6df0158e1cbe
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FAT4 ABI3BP KANK2 GPC4 TLN2 DMD ANO3 DKK3	7.28e-08	175	137	8	1799a7be623dc3bf53ba580a7c47d2619969d708
ToppCell	droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CEP57L1 RFC5 ATAD2 ESCO2 CCNF BUB1 FIGNL1 TOP2A	1.12e-07	185	137	8	47c69500877b851c0c9744f5e1ef2ee0bff99168
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 ANO3 TOP2A	1.21e-07	187	137	8	e41e39fd3791acf8ae5376cc5061e196d96868ae
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 ANO3 TOP2A	1.21e-07	187	137	8	cefa211ef224e803ea9467882e2ca74d0b1492f1
ToppCell	Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative\|Multiple_Sclerosis / Disease, Lineage and Cell Type	TEDC2 RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	1.26e-07	188	137	8	6c05797a5d0635d89ffcf4aca52178687129ccb4
ToppCell	(02)_Cycling_Basal_(regeneration)\|World / shred by cell type and Timepoint	RFC5 ATAD2 ESCO2 CCNF SERPINB10 BUB1 FIGNL1 TOP2A	1.37e-07	190	137	8	53f017a11ca5ebe9025558e12cedc409cab2e5aa
ToppCell	Healthy-T/NK_proliferative\|World / disease group, cell group and cell class	TEDC2 RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	1.81e-07	197	137	8	e90be1e7e02f736b6aab14010a912b592d6f1e80
ToppCell	COVID-19_Severe-T/NK_proliferative\|COVID-19_Severe / Disease condition and Cell class	TEDC2 RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	1.81e-07	197	137	8	718a84e9a8248080f2d964e7c6a3ba183ece9592
ToppCell	COVID-19_Moderate-T/NK_proliferative\|COVID-19_Moderate / disease group, cell group and cell class	TEDC2 RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	1.88e-07	198	137	8	166c000fb0e19602ffdd8bf2b2f19be2c6df96a6
ToppCell	COVID-19_Moderate-T/NK_proliferative\|World / disease group, cell group and cell class	TEDC2 RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	1.88e-07	198	137	8	bf0131fbca6032e1aab4aa807f8c1d3be689cb7f
ToppCell	COVID-19_Severe-T/NK_proliferative\|World / disease group, cell group and cell class	TEDC2 RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	1.88e-07	198	137	8	48045689d0969ff0a14eee7086b8e19b0d6b6065
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TEDC2 RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	1.95e-07	199	137	8	11c3d9fe811a4619347f47d2b0e94066e3085625
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	TEDC2 RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	1.95e-07	199	137	8	e98ff036d04fc78dffef156bdc0d644532274067
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TEDC2 RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	1.95e-07	199	137	8	36c80907b2ec1cbcd1b4e841e6c02a4792591d74
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	TEDC2 RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	1.95e-07	199	137	8	bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c
ToppCell	COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative\|COVID-19_Mild / Disease group, lineage and cell class	TEDC2 RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	1.95e-07	199	137	8	ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TEDC2 RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	1.95e-07	199	137	8	7feedb0bf84a3361c8ab5b6674ff64e8ff140c23
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TEDC2 RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	1.95e-07	199	137	8	7beb0e07a27fea94674f24eb61c381b0de38ed3e
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TEDC2 RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	1.95e-07	199	137	8	123fbf2122aa221d8cbf3aef9361ba0982c07695
ToppCell	COVID-19_Mild-T/NK_proliferative\|COVID-19_Mild / Disease condition and Cell class	TEDC2 RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	1.95e-07	199	137	8	9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7
ToppCell	COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative\|COVID-19_Severe / Disease group, lineage and cell class	TEDC2 RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	1.95e-07	199	137	8	ddae7fe7633661f15d3c79f5187415ffbfecce67
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TEDC2 RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	1.95e-07	199	137	8	6b1304417cf9c44ca70d2bfc2b5acc1a206f25b6
ToppCell	mild-T/NK_proliferative\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RFC5 ATAD2 ESCO2 CCNF CEP78 BRCA2 BUB1 TOP2A	2.03e-07	200	137	8	63cc57b9331459efbb73051d174d198a3568b938
ToppCell	390C-Myeloid-Dendritic-cDC_proliferating_1\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	1.07e-06	172	137	7	6fcc16f1067672967ecbcdfdc727649ae9891dd9
ToppCell	3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ATAD2 ESCO2 SERPINB10 BRCA2 BUB1 FIGNL1 TOP2A	1.16e-06	174	137	7	46cbb462173a684ceb9e680f9259dc3b133763f7
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TEDC2 CSMD2 ATAD2 ESCO2 CEP78 BRCA2 TOP2A	1.40e-06	179	137	7	80112c686a8f85ad5e3cda6e3f3d3d51cf688092
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TEDC2 CSMD2 ATAD2 ESCO2 BRCA2 BUB1 TOP2A	1.45e-06	180	137	7	f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df
ToppCell	droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PRUNE2 ESCO2 CCNF AFP BUB1 FIGNL1 TOP2A	1.74e-06	185	137	7	57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	NUGGC ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	1.74e-06	185	137	7	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 ABCC4 KANK1 SYNE2 GPC4 TLN2 NRG3	1.80e-06	186	137	7	b87acc80b7baa41681e4ed11d5537b9fbf5832f5
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	TNRC6B SIK3 LNPEP SYNE2 TMEM131 UTRN ZC3HAV1	1.93e-06	188	137	7	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	NS-critical-d_0-4-Lymphoid-NKT-proliferating\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CEP57L1 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.00e-06	189	137	7	d6bd46abb072b13a6b72f1ca25d19f218cceb1ff
ToppCell	PBMC-Severe-cDC_12\|Severe / Compartment, Disease Groups and Clusters	TEDC2 CEP57L1 ATAD2 CEP78 BRCA2 BUB1 TOP2A	2.08e-06	190	137	7	84ee185939bdefb10705b621a70da27701eadcee
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RBM20 ESCO2 CCNF BUB1 DNAH8 FIGNL1 TOP2A	2.08e-06	190	137	7	b99271d139c8d01e20feb95d99f79c9b2756b4cb
ToppCell	pdx-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.08e-06	190	137	7	d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T\|GI_small-bowel / Manually curated celltypes from each tissue	TEDC2 ATAD2 KANK2 ESCO2 BRCA2 BUB1 TOP2A	2.15e-06	191	137	7	e642fa7395c05fb53324c9d46bbc52f89fc9673f
ToppCell	facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HAUS3 RFC5 ATAD2 CCNF BUB1 FIGNL1 TOP2A	2.23e-06	192	137	7	e8d47504b744040a762ec9b670a66cc060b2ae86
ToppCell	PSB-critical-LOC-Epithelial-FOXN4+\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TEDC2 ATAD2 KANK2 CEP78 BRCA2 BUB1 TOP2A	2.30e-06	193	137	7	b7d9c5bed524423e92f01496a9f8fad11b33a3f7
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.38e-06	194	137	7	f39a471293ecc5c5967b00e772b8f48ebc9affbe
ToppCell	P28-Mesenchymal-myocytic_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PLIN4 GRIN2A SLC11A1 GPC4 COL14A1 DMD DKK3	2.38e-06	194	137	7	83e45441c74b7f50b6725876b583229280179dc2
ToppCell	Control-Lymphoid_T/NK-T/NK_proliferative\|Control / Disease group, lineage and cell class	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.38e-06	194	137	7	9bbb124001fba7450f4639f47f9b720a483e7242
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.38e-06	194	137	7	a75ecd0b0a928d4646602f7d16a645f6b3df3af5
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.38e-06	194	137	7	17744fd6645cf5a447a01a83f07e8d305c2bcd9c
ToppCell	PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.38e-06	194	137	7	e14f66f7584909621b776292fbd52808273fd2ee
ToppCell	droplet-Thymus-nan-3m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RFC5 ATAD2 ESCO2 CCNF BUB1 FIGNL1 TOP2A	2.47e-06	195	137	7	7ae732f100e9a3c6062be5b877efa1ec9d5b3958
ToppCell	E12.5-Mesenchymal-developing_mesenchymal_cell\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	HAUS3 RFC5 ESCO2 CCNF BUB1 FIGNL1 TOP2A	2.47e-06	195	137	7	97b2ff072cc830a4a2cb217f5a215ca6cad505ec
ToppCell	(1)_T_cells-(1)_T_cells_Dividing\|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.47e-06	195	137	7	cf00a0b4f341f0487d5b37810abe2952fdd3f6f2
ToppCell	mild-Lymphocytic-Prol._cells\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.47e-06	195	137	7	9a8cc9097a349fd0a53ccf2723ee8bb1418d6aca
ToppCell	droplet-Thymus-nan-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RFC5 ATAD2 ESCO2 CCNF BUB1 FIGNL1 TOP2A	2.47e-06	195	137	7	043e2f19d95e94cd5219e2c415f322ed340aa80f
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.55e-06	196	137	7	9591a6a3477ed6a1e2e016f7542e38603d8b16cb
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	TEDC2 RFC5 ATAD2 ESCO2 BRCA2 FIGNL1 TOP2A	2.55e-06	196	137	7	df366d76ea55f49e349d622effa57c1535df8400
ToppCell	mild-Lymphocytic-Prol._cells\|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.55e-06	196	137	7	b1d9866d5dfaefdb8bedaf01a750d97987acb3d1
ToppCell	Healthy-T/NK_proliferative\|Healthy / disease group, cell group and cell class	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.55e-06	196	137	7	91e44aabb2e85dcc77ddae6f7e000118d45d1de6
ToppCell	Control-T/NK_proliferative\|Control / Disease condition and Cell class	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.55e-06	196	137	7	7b7bc25aef49bfd64f79303a92d527bf8188f7a6
ToppCell	ICU-SEP-Lymphocyte-T_NK-T_NK_proliferative\|ICU-SEP / Disease, Lineage and Cell Type	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.64e-06	197	137	7	908e91fa16134b61943aea5e8fc0d6fbac8a8c6e
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZAN ABI3BP PKHD1L1 ESCO2 BRCA2 BUB1 TOP2A	2.64e-06	197	137	7	76b61e60a757e58b465569538e632d6d9953e89a
ToppCell	distal-mesenchymal-Vascular_Smooth_Muscle-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	KANK2 RBM20 RANBP3L GPC4 COL14A1 DMD DKK3	2.64e-06	197	137	7	da653dc7d216e202f390e5ab0245f243e3ed213b
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RFC5 ATAD2 ESCO2 CCNF BUB1 FIGNL1 TOP2A	2.64e-06	197	137	7	a0d463825b62de49466f9fa563405dda4387cfff
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK\|lymph-node_spleen / Manually curated celltypes from each tissue	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.73e-06	198	137	7	b2868a897dd96494cf1829c30e0ce508f52efdf3
ToppCell	severe_COVID-19-T/NK_proliferative\|severe_COVID-19 / disease group, cell group and cell class (v2)	TEDC2 RFC5 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.73e-06	198	137	7	ed86b0247006befe55400c287d334d2202b470bd
ToppCell	(3)_DC_Monocyte_Dividing\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.73e-06	198	137	7	e2b89f6d7c0007ccab62495cd543fe0e5513a9a4
ToppCell	distal-1-Hematologic-Proliferating_Macrophage\|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.73e-06	198	137	7	df3f5559ecd1f3cd1fd60e39dbad8741309e83a3
ToppCell	distal-Hematologic-Proliferating_Macrophage-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.73e-06	198	137	7	2b0716e900bce54ad1825d6dcdaf4ebf31f355c4
ToppCell	cycling_basal_cell\|World / shred by cell class for turbinate	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.73e-06	198	137	7	e86c1224f5b0890a50a25257628e90c790aae7cd
ToppCell	Leuk-UTI-Lymphocyte-T_NK-T_NK_proliferative\|Leuk-UTI / Disease, Lineage and Cell Type	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.82e-06	199	137	7	87113d398585076ece86b9098781e817f8ca241b
ToppCell	VE-cycling\|VE / Condition, Cell_class and T cell subcluster	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.82e-06	199	137	7	47c47ebc318a0b98841ca2656837bbd068899559
ToppCell	3'_v3-bone_marrow-Lymphocytic_NK-Cycling_NK\|bone_marrow / Manually curated celltypes from each tissue	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.82e-06	199	137	7	6321140a1ebc1ff793fb6221a31e884368e42fa5
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	TEDC2 ATAD2 ESCO2 BRCA2 SYNE2 BUB1 TOP2A	2.82e-06	199	137	7	101f78fe6dd1bf9e2e4dd5ad8a970312b3540927
ToppCell	NS-critical-d_16-33-Lymphoid-NKT-proliferating\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	NUGGC TEDC2 ATAD2 ESCO2 CCNF BUB1 TOP2A	2.82e-06	199	137	7	31b144bb209c629e12156f4d9c9cec79baffffb9
ToppCell	PBMC-Mild-Lymphocyte-T/NK-Other_T\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TEDC2 ATAD2 ESCO2 BRCA2 SYNE2 BUB1 TOP2A	2.82e-06	199	137	7	e0fcec796afe75e42467ca86355b9fc5aa9ae0a1
ToppCell	367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.82e-06	199	137	7	88d130e2451e61afb710edf552e6b346b9fcfb2b
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	TBC1D5 TNRC6B BCKDHB SIK3 TNRC6A DMD UTRN	2.82e-06	199	137	7	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ATAD2 ESCO2 CCNF BRCA2 BUB1 NRG3 TOP2A	2.82e-06	199	137	7	1d5a3366474c17e3df0ba5cf11b586655529e9bd
ToppCell	VE-cycling-\|VE / Condition, Cell_class and T cell subcluster	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.82e-06	199	137	7	c0a67149a19b65b3069dbc5261d81f658e6e39a2
ToppCell	COVID-19_Severe-T/NK_proliferative\|COVID-19_Severe / disease group, cell group and cell class	TEDC2 RFC5 ATAD2 ESCO2 CCNF BUB1 TOP2A	2.82e-06	199	137	7	af78837f3a7641a5bd98765eef9cb4f86034048c
ToppCell	LPS_IL1RA-Endothelial-Endothelial-FOXM1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ATAD2 ESCO2 CCNF BRCA2 SYNE2 BUB1 TOP2A	2.82e-06	199	137	7	be2276c9a1994579ba1d2998b49bf549c1324d44
ToppCell	mild_COVID-19-T/NK_proliferative\|mild_COVID-19 / disease group, cell group and cell class (v2)	TEDC2 RFC5 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.82e-06	199	137	7	df2fcaf01b1b48632f84e7355ef21d20853f0664
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors\|1_mon / Sample Type, Dataset, Time_group, and Cell type.	FAT4 RYK STAT1 TMEM131 DMD UTRN TOP2A	2.82e-06	199	137	7	358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-T/NK_proliferative\|COVID-19_Mild / Disease, condition lineage and cell class	RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.91e-06	200	137	7	6126a3bbafe2110fba0c1c4493035df4e8193d22
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	ENKUR ATAD2 ESCO2 BRCA2 BUB1 GPC4 TOP2A	2.91e-06	200	137	7	31dd81df9aa754a1e69b905bf9b8ce73ff8175aa
ToppCell	Control_saline-Endothelial-Endothelial-FOXM1\|Control_saline / Treatment groups by lineage, cell group, cell type	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.91e-06	200	137	7	9bbc7b5561151f6ff65f40b3226271def732e5d9
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Stem_cells-Neuroepithelial_cell\|5w / Sample Type, Dataset, Time_group, and Cell type.	TEDC2 RFC5 ATAD2 ESCO2 BRCA2 BUB1 TOP2A	2.91e-06	200	137	7	c865efaaaecccbf9c833d6c1cbe85809a3ec306d
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-T/NK_proliferative\|COVID-19_Severe / Disease, condition lineage and cell class	RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.91e-06	200	137	7	0892603e604c2a945dd720685d45970f855bd5d3
ToppCell	healthy_donor-Lymphocytic-Proliferative_Lymphocyte\|healthy_donor / Disease condition, Lineage, Cell class and subclass	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.91e-06	200	137	7	e4eb915c29909cf8535a3603c68976545c05e54b
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells-Neuroepithelial_cell\|GW19 / Sample Type, Dataset, Time_group, and Cell type.	ENKUR ATAD2 ESCO2 BRCA2 BUB1 GPC4 TOP2A	2.91e-06	200	137	7	54174a485a82480726fa06efa6e050ddea77cb3c
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Stem_cells\|5w / Sample Type, Dataset, Time_group, and Cell type.	TEDC2 RFC5 ATAD2 ESCO2 BRCA2 BUB1 TOP2A	2.91e-06	200	137	7	2ee167b8bddd11fd5b1f61f87fcdf757aee3193e
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW09-Stem_cells-Stem_cells\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	RFC5 ATAD2 ESCO2 SYNE2 GPC4 UTRN TOP2A	2.91e-06	200	137	7	c00cc0b91baa37828895d9d6b8acbc6aa503215a
ToppCell	mild-T/NK_proliferative\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.91e-06	200	137	7	25b4a1a33348e274bd4457efc0d6faa5421c3d31
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW09-Stem_cells\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	RFC5 ATAD2 ESCO2 SYNE2 GPC4 UTRN TOP2A	2.91e-06	200	137	7	9e1b62a703fb7d413ce580448a1df5127c28e8a7
ToppCell	healthy_donor-Lymphocytic-Proliferative_Lymphocyte-\|healthy_donor / Disease condition, Lineage, Cell class and subclass	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.91e-06	200	137	7	415e7556b5ac45688e2c6c30a52bd40e0eb27c7d
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	PRUNE2 ABI3BP KANK2 MAP4K5 GPC4 DMD DKK3	2.91e-06	200	137	7	593bf6a7c557437db9a9249a5058a46014179ef6
ToppCell	MS-Multiple_Sclerosis-Lymphocyte-T/NK-T/NK_proliferative\|Multiple_Sclerosis / Disease, condition lineage and cell class	RFC5 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.91e-06	200	137	7	7faf1e37364203a08d2b2544979e848b41e36b1c
ToppCell	NS-critical-d_07-13-Lymphoid-NKT-proliferating\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TEDC2 ATAD2 ESCO2 CCNF BRCA2 BUB1 TOP2A	2.91e-06	200	137	7	7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	PRUNE2 ABI3BP KANK2 MAP4K5 GPC4 DMD DKK3	2.91e-06	200	137	7	02cae2c296a13ad4cbb53bca7a86d64629d67d66
Drug	Adamantamine fumarate [80789-67-9]; Down 200; 9.6uM; HL60; HT_HG-U133A	DCTN5 TBC1D5 ECPAS RFC5 RYK STAT1 SERPINB10 BRCA2 PLEC UTRN	1.43e-07	184	134	10	1344_DN
Disease	level of Ceramide (d40:1) in blood serum	SIK3 MAP4K5 SYNE2	1.34e-05	11	130	3	OBA_2045185
Disease	factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement	MAP4K5 PLEC MCF2L TBL2	1.11e-04	56	130	4	EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791
Disease	breast cancer (implicated_via_orthology)	APC STAT1 BRCA2	1.79e-04	25	130	3	DOID:1612 (implicated_via_orthology)
Disease	reticulocyte count	ENKUR TNRC6B KANK2 STAT1 ABCB4 AP1B1 RANBP3L MAP4K5 SYNE2 PKD1 TLN2 TMEM131 UBE2Z ZC3HAV1	2.16e-04	1045	130	14	EFO_0007986
Disease	Colorectal cancer	APC MLH3 BUB1	2.26e-04	27	130	3	cv:C0346629
Disease	COLORECTAL CANCER	APC MLH3 BUB1	2.26e-04	27	130	3	114500
Disease	Neoplasm of the large intestine	APC MLH3 BUB1	2.26e-04	27	130	3	cv:C0009404
Disease	reticulocyte measurement	ENKUR TNRC6B ECPAS KANK2 STAT1 ABCB4 AP1B1 RANBP3L MAP4K5 SYNE2 TLN2 TMEM131 UBE2Z ZC3HAV1	2.34e-04	1053	130	14	EFO_0010700
Disease	susceptibility to mononucleosis measurement	FAT4 DNAH2 DMD DNAH8	2.49e-04	69	130	4	EFO_0008403
Disease	neuroimaging measurement	TBC1D5 LRRC49 APC TNRC6B RFC5 TFAP4 STAT1 PKD1 TNRC6A TLN2 PLEC TUBD1 TBL2 UBE2Z	2.72e-04	1069	130	14	EFO_0004346
Disease	WILMS TUMOR 1	BRCA2 GPC4	2.86e-04	6	130	2	194070
Disease	Wilms tumor 1	BRCA2 GPC4	2.86e-04	6	130	2	cv:CN033288
Disease	calcium measurement	ABCC4 DNAH2 SIK3 NFU1 MAP4K5 NYNRIN SYNE2 HFM1 TMEM131 PLEC	4.81e-04	628	130	10	EFO_0004838
Disease	resting heart rate	EPPK1 LZIC MAP4K5 TANC1 PLEC	5.29e-04	149	130	5	EFO_0004351
Disease	Nephroblastoma	BRCA2 GPC4	5.30e-04	8	130	2	cv:C0027708
Disease	Leprosy	SLC11A1 TLR1	5.30e-04	8	130	2	C0023343
Disease	leprosy (is_implicated_in)	SLC11A1 TLR1	5.30e-04	8	130	2	DOID:1024 (is_implicated_in)
Disease	Hereditary Wilms tumor	BRCA2 GPC4	5.30e-04	8	130	2	cv:C0677779
Disease	Kidney Wilms tumor	BRCA2 GPC4	5.30e-04	8	130	2	cv:CN305775
Disease	endometrial cancer (is_implicated_in)	APC MLH3 BRCA2	5.36e-04	36	130	3	DOID:1380 (is_implicated_in)
Disease	Lynch Syndrome	APC MLH3	6.80e-04	9	130	2	C4552100
Disease	cystic fibrosis (implicated_via_orthology)	ABCC4 ABCB4	6.80e-04	9	130	2	DOID:1485 (implicated_via_orthology)
Disease	Coffin-Siris syndrome (implicated_via_orthology)	SMARCD1 SMARCD2	6.80e-04	9	130	2	DOID:1925 (implicated_via_orthology)
Disease	cholestasis (implicated_via_orthology)	LAMP2 ABCB4	6.80e-04	9	130	2	DOID:13580 (implicated_via_orthology)
Disease	medulloblastoma (is_implicated_in)	APC BRCA2	8.47e-04	10	130	2	DOID:0050902 (is_implicated_in)
Disease	ptosis (implicated_via_orthology)	TUBB8 TUBB8B	8.47e-04	10	130	2	DOID:0060260 (implicated_via_orthology)
Disease	tubulinopathy (implicated_via_orthology)	TUBB8 TUBB8B	8.47e-04	10	130	2	DOID:0112227 (implicated_via_orthology)
Disease	level of Triacylglycerol (51:3) in blood serum	SIK3 MAP4K5	8.47e-04	10	130	2	OBA_2045163
Disease	facial paralysis (implicated_via_orthology)	TUBB8 TUBB8B	8.47e-04	10	130	2	DOID:13934 (implicated_via_orthology)
Disease	complex cortical dysplasia with other brain malformations 7 (implicated_via_orthology)	TUBB8 TUBB8B	8.47e-04	10	130	2	DOID:0090132 (implicated_via_orthology)
Disease	triglycerides in large LDL measurement	SIK3 MAP4K5 SYNE2	9.07e-04	43	130	3	EFO_0022319
Disease	level of Diacylglycerol (18:1_18:1) in blood serum	SIK3 MAP4K5	1.03e-03	11	130	2	OBA_2045170
Disease	insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation	TNRC6B TLN2	1.03e-03	11	130	2	EFO_0004471, EFO_0009131
Disease	Malignant neoplasm of kidney	ESCO2 BRCA2 FIGNL1	1.04e-03	45	130	3	C0740457
Disease	cerebellar ataxia, mental retardation and dysequlibrium syndrome (implicated_via_orthology)	TUBB8 TUBB8B	1.24e-03	12	130	2	DOID:0050997 (implicated_via_orthology)
Disease	alpha-hydroxybutyric acid measurement	ABCC4 MAP4K5	1.24e-03	12	130	2	EFO_0010458
Disease	level of Diacylglycerol (18:1_18:2) in blood serum	SIK3 MAP4K5	1.24e-03	12	130	2	OBA_2045171
Disease	omega-6:omega-3 polyunsaturated fatty acid ratio	MAP4K5 HFM1 NRG3	1.41e-03	50	130	3	EFO_0010732
Disease	Benign tumor of pancreas	APC BRCA2	1.46e-03	13	130	2	C0347284
Disease	Colorectal Neoplasms	ABCC4 APC GRIN2A ABCB4 MLH3 BUB1	1.46e-03	277	130	6	C0009404
Disease	triglyceride measurement, intermediate density lipoprotein measurement	BRCA2 MAP4K5 NYNRIN SYNE2	1.50e-03	111	130	4	EFO_0004530, EFO_0008595
Disease	free cholesterol to total lipids in small LDL percentage	SIK3 MAP4K5 TGDS	1.67e-03	53	130	3	EFO_0022286
Disease	Kartagener syndrome (implicated_via_orthology)	AP1B1 DNAH5	1.69e-03	14	130	2	DOID:0050144 (implicated_via_orthology)
Disease	factor VII measurement	MAP4K5 MCF2L TBL2	1.85e-03	55	130	3	EFO_0004619
Disease	Liver carcinoma	TEDC2 APC STAT1 ABCB4 CCNF AFP BUB1 TOP2A	1.88e-03	507	130	8	C2239176
Disease	triacylglycerol 52:3 measurement	SIK3 MAP4K5	1.95e-03	15	130	2	EFO_0010415
Disease	level of Triacylglycerol (53:3) in blood serum	SIK3 MAP4K5	1.95e-03	15	130	2	OBA_2045165
Disease	triglycerides in LDL measurement	SIK3 MAP4K5 SYNE2	1.95e-03	56	130	3	EFO_0022320
Disease	triglycerides in chylomicrons and extremely large VLDL measurement	SIK3 MAP4K5 TGDS	1.95e-03	56	130	3	EFO_0022316
Disease	colorectal cancer (is_implicated_in)	APC GRIN2A MLH3 BUB1	2.05e-03	121	130	4	DOID:9256 (is_implicated_in)
Disease	fibrinogen measurement, factor VII measurement	MAP4K5 PLEC MCF2L	2.16e-03	58	130	3	EFO_0004619, EFO_0004623
Disease	Intrahepatic cholestasis of pregnancy	ABCB4 MAP4K5	2.22e-03	16	130	2	EFO_0009048
Disease	concentration of chylomicrons and extremely large VLDL particles measurement	SIK3 MAP4K5 TGDS	2.27e-03	59	130	3	EFO_0022260
Disease	cholesterol in chylomicrons and extremely large VLDL measurement	SIK3 MAP4K5 TGDS	2.38e-03	60	130	3	EFO_0021898
Disease	unipolar depression, response to selective serotonin reuptake inhibitor, mood disorder	FSTL4 BPNT2	2.51e-03	17	130	2	EFO_0003761, EFO_0004247, EFO_0005658
Disease	total lipids in chylomicrons and extremely large VLDL measurement	SIK3 MAP4K5 TGDS	2.61e-03	62	130	3	EFO_0022306
Disease	free cholesterol in chylomicrons and extremely large VLDL measurement	SIK3 MAP4K5 TGDS	2.61e-03	62	130	3	EFO_0022263
Disease	Cardiomyopathies	SGCB LAMP2 RBM20 DMD	2.66e-03	130	130	4	C0878544
Disease	free cholesterol to total lipids in medium LDL percentage	SIK3 MAP4K5 TGDS	2.74e-03	63	130	3	EFO_0022283
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	SIK3 MAP4K5 TGDS	2.74e-03	63	130	3	EFO_0022292
Disease	apolipoprotein B measurement	TBX21 SIK3 KANK2 ABCB4 BRCA2 MAP4K5 NYNRIN SYNE2 PLEC	2.74e-03	663	130	9	EFO_0004615
Disease	bitter alcoholic beverage consumption measurement	DNAH2 TNRC6B MAP4K5 TNRC6A	2.89e-03	133	130	4	EFO_0010092
Disease	primary ciliary dyskinesia (implicated_via_orthology)	AP1B1 DNAH5	3.14e-03	19	130	2	DOID:9562 (implicated_via_orthology)
Disease	Pancreatic carcinoma	APC BRCA2	3.14e-03	19	130	2	C0235974
Disease	Hypertriglyceridemia	MAP4K5 TBL2	3.14e-03	19	130	2	EFO_0004211
Disease	Cholecystitis	ABCB4 MAP4K5	3.14e-03	19	130	2	HP_0001082
Disease	Grand Mal Status Epilepticus	LAMP2 GRM1 DMD	3.26e-03	67	130	3	C0311335
Disease	Status Epilepticus, Subclinical	LAMP2 GRM1 DMD	3.26e-03	67	130	3	C0751522
Disease	Simple Partial Status Epilepticus	LAMP2 GRM1 DMD	3.26e-03	67	130	3	C0751524
Disease	Non-Convulsive Status Epilepticus	LAMP2 GRM1 DMD	3.26e-03	67	130	3	C0751523
Disease	Petit mal status	LAMP2 GRM1 DMD	3.26e-03	67	130	3	C0270823
Disease	Complex Partial Status Epilepticus	LAMP2 GRM1 DMD	3.26e-03	67	130	3	C0393734
Disease	Status Epilepticus	LAMP2 GRM1 DMD	3.40e-03	68	130	3	C0038220
Disease	forced expiratory volume, response to bronchodilator	EPPK1 ABI3BP FSTL4 SIK3 FCER2 PLEC DNAH5	3.65e-03	445	130	7	EFO_0004314, GO_0097366
Disease	muscular dystrophy (implicated_via_orthology)	DMD UTRN	3.83e-03	21	130	2	DOID:9884 (implicated_via_orthology)
Disease	prothrombin time measurement	MAP4K5 MCF2L	3.83e-03	21	130	2	EFO_0008390
Disease	Colorectal Carcinoma	ABCC4 APC GRIN2A GRM1 ABCB4 MLH3 BUB1 DMD DNAH8	3.99e-03	702	130	9	C0009402
Disease	testosterone measurement	POLR1A ZAN DLGAP4 DNAH2 RYK UBE3D MAP4K5 NYNRIN SYNE2 TGDS C18orf63 UTRN TBL2	4.19e-03	1275	130	13	EFO_0004908
Disease	amblyopia	BCKDHB MALRD1	4.20e-03	22	130	2	MONDO_0001020
Disease	triacylglycerol 54:6 measurement	SIK3 MAP4K5	4.20e-03	22	130	2	EFO_0010424
Disease	aspartate aminotransferase to alanine aminotransferase ratio	PRUNE2 EPPK1 ABCB4 NYNRIN PLEC	4.22e-03	239	130	5	EFO_0010934

Protein segments in the cluster

Peptide	Gene	Start	Entry
MLSVVKNQNIGFNNA	ALG11	206	Q2TAA5
QVLNQMITSKSNPGN	BUB1	166	O43683
VTGFQVANSKVNATM	CSMD2	3296	Q7Z408
KGMFAINQVTGQLTT	FAT4	836	Q6V0I7
QVGSISMDLQLTNKA	AP1B1	741	Q10567
GVNQSMLFDKLITNT	ATAD2	166	Q6PL18
ALGQMQNIQFQKITG	CEP78	591	Q5JTW2
NIMAGLQQTNSEKIL	DMD	126	P11532
SGKSLSMFQQQLEQS	DNHD1	3171	Q96M86
IAEMQGKLATFQNQI	CCDC154	526	A6NI56
VGSAQLLMSQKFQQF	DLGAP4	846	Q9Y2H0
QVVGLKFLTNMTITN	ARMCX2	486	Q7L311
GSIQSFKQQKGMNIS	ANO3	6	Q9BYT9
ITRNMNTNIKNGILS	RAD51AP2	551	Q09MP3
NQVLSKVAMSQPLFN	RBM20	121	Q5T481
SGLKTQRNTSINMQL	NRG3	556	P56975
GQTQKMNLFQSVTSA	BCKDHB	66	P21953
NVLQLAKEQSMSSVG	GDAP2	151	Q9NXN4
GISVANQTVEQLQKM	CASK	541	O14936
QSGLSINNVFKMSSV	FIGNL1	101	Q6PIW4
MQSVIAFATVLTQNQ	LRRC34	221	Q8IZ02
GMQLAIQAAISQAFK	LZIC	76	Q8WZA0
SIITLKNGIQNMLQF	NFU1	216	Q9UMS0
TGLNTQTQQLLMTVK	NLRP11	956	P59045
MQDNSVQVSQKVFQG	GPC4	326	O75487
ISNMKNLGTLVLSNN	LRRC39	241	Q96DD0
KVQLGVLQSMNAFFQ	ECPAS	1731	Q5VYK3
STTVNGMAANILKNN	MLH3	531	Q9UHC1
TKINGLEVQIQAFMN	DNAH8	431	Q96JB1
GDQMAQKSQSTQISQ	FCER2	76	P06734
VNAKASQAGQTALML	KANK1	1226	Q14678
HFSMQKINGTEVTQN	LRRC49	521	Q8IUZ0
MKNLSQDVNGTLVSI	LNPEP	366	Q9UIQ6
TMGLQLNITQDKVAS	LAMP2	236	P13473
QALQTFAKTSGTMNN	MICAL1	891	Q8TDZ2
MQEFANGLLNKVVTS	SLC11A1	456	P49279
LQMTKQVNNGLTLSD	FBXO25	216	Q8TCJ0
SGMVKQVALQTFGNQ	BPNT2	246	Q9NX62
QAGSILMTVNTLQGK	CCDC182	6	A6NF36
TNMQGFTKSLNAFNV	HDAC3	76	O15379
ANITFLSINMKNVLQ	IL20RA	41	Q9UHF4
KLVNMQTSGSQIQSE	ABCB4	626	P21439
GNQITMQRKSETQIS	HFM1	1101	A2PYH4
MGKTTTGQIVNLLSN	ABCC4	186	O15439
GALTLMQVSVTNQTK	MALRD1	1396	Q5VYJ5
QLILQNNIEMTTGTF	BRCA2	1291	P51587
QQVFSVQKGLNDTMR	CCNF	296	P41002
GEVVQSSNTNQMVFK	FAHD2B	241	Q6P2I3
KSVFEQSLSQQGLMN	FOXJ3	301	Q9UPW0
NLQNTATKAIIQGLM	COL14A1	76	Q05707
VSTQMSKQLSLLANG	FSTL4	381	Q6MZW2
SQGILNAMITKISNE	HAUS3	151	Q68CZ6
SQNIVLNGKTIVMND	DCTN5	31	Q9BTE1
VMGIQSGKNFINTNA	ENKUR	96	Q8TC29
SVGSVNFMKQTNIQK	ESCO2	346	Q56NI9
FFLKNALVSTLGQMQ	FBXO24	156	O75426
VKQTAQMLQSFGTEL	MCF2L	241	O15068
INAKASQAGQTALML	KANK2	731	Q63ZY3
LQQKVQNSKMSEASG	CEP57L1	391	Q8IYX8
GANIQSIMASEKQVN	EXOC1	201	Q9NV70
QQKSLMDQLQGVVSN	GRM1	1026	Q13255
QQQKRLTTGLMTQAE	FAM27D1	36	Q5T7N8
QQTQRKMLLDVTTGQ	C4orf54	1606	D6RIA3
KIQTQISSGMTNNAS	DNAH2	936	Q9P225
QIKVLNIGNNTMNIS	SLC15A1	396	P46059
MQLNLTVNSSKNFTV	RYK	171	P34925
HKITNNQTGQMVFSE	DKK3	116	Q9UBP4
FLSQMGKQSAVVLNI	C18orf63	131	Q68DL7
QESLKLMTAGNFLQN	DNAH5	3351	Q8TE73
QGVALQTMKQEFLIN	AFP	541	P02771
NNTLMSLSVGKTFQL	MAP4K5	561	Q9Y4K4
TKVASMAFQTQAGAQ	PKD1	2846	P98161
TAQLMATAQKTVVNQ	NYNRIN	596	Q9P2P1
KGAMQTGLNTTQNIA	PLIN4	401	Q96Q06
SSNQVTQAVAKLGMS	UTRN	631	P46939
AGKSSLINAIIQQAM	NUGGC	111	Q68CJ6
TNGQTVNLQAVMKDV	POLR1A	321	O95602
QSGNIQSTVMLDKQK	STAT1	126	P42224
QFSAQGLSIEQTMLK	PRUNE2	216	Q8WUY3
KTQMNSFLLSTASQQ	SMARCD1	401	Q96GM5
MENLQTNFSLVQGST	SKIL	1	P12757
VTGQVLKNSSATMNL	TAAR6	326	Q96RI8
VLTQVNQLKTSMQSV	SYNE2	5261	Q8WXH0
AKFQQLANISMSGNN	SYNE2	5406	Q8WXH0
AAAAKTQFLQNMQTA	TEDC2	236	Q7L2K0
KFLVTQMAGFLANQQ	NBPF7P	61	P0C2Y1
ALNILQSTNMAFGKV	RFC5	216	P40937
TGQQISLFQAMQKGL	EPPK1	696	P58107
GQQISLFQAMQKDLI	EPPK1	2316	P58107
TGQQISLFQAMQKDL	EPPK1	2851	P58107
TGQQISLFQAMQKDL	EPPK1	3916	P58107
GQQISLFQAMQKDLI	EPPK1	4451	P58107
KGNTAAQMAQILSFN	SERPINB6	46	P35237
VLSQSSLMGSQQFQD	SIK3	1251	Q9Y2K2
KTNFTNLLGGLQSMV	SLC25A41	126	Q8N5S1
AVRNGSMKVQISSQN	TANC1	1546	Q9C0D5
MVSQLSRGKQAFTQQ	MYH4	1301	Q9Y623
ADGTLFKVQVTSQNM	SGCB	291	Q16585
FKVQVTSQNMGCQIS	SGCB	296	Q16585
EIFSNMNIKNFTVSG	TLR1	321	Q15399
LKAQMSNFLASTTNQ	SMARCD2	416	Q92925
VGNVLVMISFKVNSQ	CHRM5	46	P08912
LAQKSGNIINMSSVA	BDH2	121	Q9BUT1
RQMSQQNLTKQTGLS	APC	2371	P25054
NIGTNFEMSVVQLAK	TGDS	256	O95455
VVMKFQFTRNNNGAS	TMPRSS11D	116	O60235
LQFDINSVGKQTGMT	FYTTD1	276	Q96QD9
KVINQMLSKAAQSGQ	TUBD1	71	Q9UJT1
NLMQSINQSKKTVFV	TLR8	931	Q9NR97
LKNQIFTGIQMQTRS	ZNF562	106	Q6V9R5
TSQKMFVNTKAVQGV	MIOS	216	Q9NXC5
LKMSATFIGNNTAIQ	TUBB8	361	Q3ZCM7
ATTQKQEQIINTMTQ	TPR	751	P12270
QNFLRTQMGNTTTVN	RYR3	3751	Q15413
MGQQISDQTQLVINK	RNF141	1	Q8WVD5
QSQGVRKNNVFMTSA	RANBP3L	86	Q86VV4
TGSIQNNMLTLNLVK	THAP5	156	Q7Z6K1
TKLISMFNQSSQTQE	UBE3D	91	Q7Z6J8
QSLNIMNSFSQKVKI	TMEM131	691	Q92545
LKMSATFIGNNAAIQ	TUBB8B	361	A6NNZ2
TKINMNGVNSSNGVV	UBE2V1	86	Q13404
FQVNQTKTNGPTMTN	PKHD1L1	861	Q86WI1
MLTALGQVNNIQKEF	PRO1716	1	Q9UHU1
QQISLFQAMQKGLIV	PLEC	2921	Q15149
KLMTTGNNTVRFNPN	UBE2Z	166	Q9H832
ISNMTFSNGKLIVNQ	TNFSF11	196	O14788
LTMSEKGFQQISFVN	TOP2A	301	P11388
EVNLSMQGKNVTVFT	ZBED5	486	Q49AG3
IQVIGNLKNISMASS	TLN2	1301	Q9Y4G6
RFVTKINMNGINNSS	UBE2V2	81	Q15819
NGLNQCLTTTQSKMF	ZNF66	131	Q6ZN08
TLIQTFQKMTVTLNF	TMEM130	251	Q8N3G9
LSFQGMIQTNIASKT	ZC3HAV1	661	Q7Z2W4
QGQSVQMSGAIKQAS	TBC1D5	686	Q92609
GKNKSIQMTNQTFST	ABI3BP	876	Q7Z7G0
IQMTNQTFSTVENLK	ABI3BP	881	Q7Z7G0
MQSINAGFQSLKTLI	TFAP4	61	Q01664
AKGTTAAQMAQVLQF	SERPINB10	46	P48595
SLKGQVLSTINTNQM	TBL2	216	Q9Y4P3
NNKGASNNVTQMIVL	TBX21	246	Q9UL17
STIGQMPNNQSINSK	TNRC6A	396	Q8NDV7
QQSKMENAGVNFVVS	TNRC6B	346	Q9UPQ9
MQLIFKGIQGSNTAS	ZAN	506	Q9Y493
EFQQIINLALQKTGM	L1TD1	101	Q5T7N2
QFGASIQQQATVMLK	GRIN2A	146	Q12879